Related Experiment Video
Updated: Jan 3, 2026

13:07
A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
12.7K
Photobiomodulation in Temporomandibular Disorders
Jan Tunér1, Sepanta Hosseinpour2, Reza Fekrazad3,4
1Private Practice, Swedish Laser Medical Society (SLMS), Stockholm, Sweden.
Photobiomodulation, Photomedicine, and Laser Surgery
|November 27, 2019
Summary
Photobiomodulation therapy (PBMT) effectively reduces pain and improves function in temporomandibular disorder (TMD) patients. Specific parameters, including GaAlAs diode laser at 800-900 nm, show promising results for pain relief and enhanced mandibular movement.
Area of Science:
- Biomedical Engineering
- Laser Therapy
- Pain Management
Background:
- Temporomandibular disorders (TMDs) involve temporomandibular joint dysfunction and masticatory muscle pain.
- Photobiomodulation therapy (PBMT) is explored as an adjunctive treatment for TMD due to its anti-inflammatory effects.
- Standardized protocols for PBMT in TMD are lacking, necessitating a comprehensive review.
Purpose of the Study:
- To systematically review all available literature on PBMT for TMD patients.
- To propose an evidence-based protocol for therapeutic PBMT administration in TMD.
- To identify optimal parameters for PBMT in managing TMD symptoms.
Main Methods:
- A systematic review of original articles on PBMT for TMDs was conducted.
- Databases searched included EMBASE, MEDLINE, Cochrane Library, Scopus, Web of Science, and Google Scholar.
- Data extraction focused on PBMT parameters, application sites, and reported outcomes.
Main Results:
- PBMT demonstrated effectiveness in reducing pain and improving mandibular function in TMD patients.
- Optimal parameters identified include GaAlAs diode laser (800-900 nm, 100-500 mW, <10 J/cm²), applied twice weekly for 30 days on trigger points.
- Reported energy densities ranged from 0.75 to 112.5 J/cm² with power from 0.9-500 mW.
Conclusions:
- PBMT is a promising therapeutic option for managing TMD symptoms, particularly pain and functional deficits.
- Despite positive outcomes, heterogeneity in study parameters complicates standardization.
- Further research with standardized protocols is recommended for clinical application and future studies.

